Establishing a prognostic model based on immune-related genes and identification of BIRC5 as a potential biomarker for lung adenocarcinoma patients

Establishing a prognostic model based on immune-related genes and identification of BIRC5 as a potential biomarker for lung adenocarcinoma patients

Abstract Background Lung adenocarcinoma (LUAD) is an extraordinarily malignant tumor, with rapidly increasing morbidity and poor prognosis. Immunotherapy has emerged as a hopeful therapeutic modality for lung adenocarcinoma. Furthermore, a prognostic model (based on immune genes) can fulfill the pur...

Full description

Bibliographic Details
Main Authors: Qianhe Ren, Qifan Li, Chenye Shao, Pengpeng Zhang, Zhuangzhuang Hu, Jun Li, Wei Wang, Yue Yu
Format: Article
Language:English
Published: BMC 2023-09-01
Series:BMC Cancer
Subjects:
lung adenocarcinoma
Immune genes
Risk signature
Prognosis
Tumor mutation burden
Immunotherapy
Online Access:https://doi.org/10.1186/s12885-023-11249-8

Internet

https://doi.org/10.1186/s12885-023-11249-8

Similar Items